The extensive development of nanoparticles (NPs) and their widespread employment in daily life have led to an increase in environmental concentrations of substances that may pose a biohazard to humans. The aim of this work was to examine the effects of zinc oxide nanoparticles (ZnO-NPs) on the host's pulmonary immune system response to nontypeable Haemophilus influenzae (NTHi) infection. Materials & Methods: A murine infection model was employed to assess pulmonary inflammation and bacterial clearance in response to exposure to ZnO-NPs. The molecular mechanisms underlying ZnO-NP-impaired macrophage activation were investigated. Results: Treatment with ZnO-NPs impaired macrophage activation, leading to a delay in NTHi clearance in the bronchial alveolar lavage fluids and lungs. Exposure to ZnONPs followed by NTHi challenge decreased levels of nitric oxide compared with NTHi infection alone. The effects of ZnO-NPs involved downregulation of NTHi-activated expression of inducible nitric oxide synthase and the translocation of active NF-kB into the nucleus. Conclusion: These results demonstrate that exposure to ZnO-NPs can impair innate immune responses and attenuate macrophage responses to bacterial infection.
Nanoparticles (NPs) are defined as particles with a diameter smaller than 100 nm that have been used widely in human living environments [1] . Nanomaterials employed in products are easily adsorbed by and penetrate into biological systems, posing a health risk to humans [2, 3] . As the use of NPs increases, the possible toxic effects on human health have raised serious concerns [4, 5] .
In recent years, zinc oxide nanoparticles (ZnO-NPs) have been synthesized and are frequently included in commonly used products, including sunscreens, cosmetic products, food and medical materials [6] [7] [8] [9] . Application of sunscreens containing ZnONPs might result in their absorption through the skin and the appearance of elevated levels of Zn in the blood and urine [10, 11] . However, several studies suggest that metal oxide nanoparticles can lodge in hair follicles, sweat glands or skin folds but not penetrate through the skin [12, 13] . It has been reported that oral administration and intraperitoneal injection of ZnO-NPs resulted in Zn absorption into the circulatory system, followed by biodistribution to the liver, spleen and kidney [14] . Exposure to uncoated ZnO-NPs may mitigate the cellular responses in human olfactory cells with varying degrees [15] . In addition, ZnO-NPs have been reported to play a role in pathogenesis in endothelial inflammation associated with cardiovascular diseases [16] . NPs possess well-known antimicrobial activity [17] , and their influence on human immune/inflammatory responses has also been reported [18, 19] . However, the toxicological relevance of ZnO-NPs in the respiratory airway, especially with respect to host future science group
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defense against bacterial infection, currently remains uncharacterized.
Haemophilus influenzae, a Gram-negative coccobacillus with a pleomorphic shape, belongs to the flora that normally colonize the human upper respiratory tract [20] . Strains without a polysaccharide capsule are designated as nontypeable H. influenzae (NTHi), and are the main cause of Haemophilus respiratory infections [21] . A large number of respiratory diseases arise from NTHi infection, including otitis media with effusion, bronchitis, pneumonia, and chronic obstructive pulmonary disease (COPD) [22] [23] [24] [25] . Deficient pulmonary immune responses may lead to acute exacerbation of chronic airway inflammation by NTHi [26] .
The aim of this study was to explore whether ZnO-NPs affect the host pulmonary immune system's response to NTHi infection. We established a nanoparticle-exposed mouse model that was challenged with NTHi to evaluate pulmonary immune responses and lung bacterial clearance. Additional studies were then carried out to investigate the effect of ZnO-NPs on triggering signaling molecules and modulating inflammasome activation, which may lead to attenuation of pulmonary immune activation in response to NTHi infection.
Materials & methods

Preparation & characterization of nanoparticles
Zinc oxide nanoparticles (ZnO-NPs) and zinc oxide microparticles (ZnO-MPs) were obtained from Jaw-Jou Kang (Graduate Institute of Toxicology, National Taiwan University, Taiwan) [14] . The particle sizes and physicochemical characteristics of ZnO-NPs and ZnO-MPs were determined by TEM (JEM-1200EX II TEM, Jeol, Japan) and dynamic light scattering (DLS; Zetasizer Nano series, Malvern Instruments Ltd, UK). The concentration of the particles that was used to characterize the physicochemical characteristics is 10 µg/ml in phosphate-buffered saline (PBS) or RPMI containing 10% FBS. As shown in Table 1 , the diameters of ZnO-NPs were approximately 50 nm, and ZnO-MPs with external diameters were more than 100 nm [14, 16] . The intensityweight average hydrodynamic diameters of ZnO-NPs and ZnO-MPs were 93 ± 14 nm and 1226 ± 120 nm, respectively (Supplementary Figure 2 ; see online at http://www.futuremedicine.com/doi/full/10.2217/ NNM.14.48). The particle suspensions were prepared using DMSO at 1, 5 and 10 µg/ml followed by sonication for 10 min and immediate application to cell experiments.
Inductively coupled plasma-mass spectrometry assay
The concentration zinc ion in RPMI medium containing 10% FBS was detected by inductively coupled plasmamass spectrometry (ICP-MS; Element, Finnigan MAT, Germany), as described previously [14] . Briefly, different concentrations of particles were incubated in RPMI medium containing 10% FBS for 3 h. The medium was collected for centrifuging at 10000 ×g. The supernatant was then prepared to analyze the zinc ion concentration by ICP-MS.
Reagents & antibodies
Antibodies against inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) were purchased from Santa Cruz Biotechnology (CA, USA). NF-kB-Luc plasmids were purchased from Stratagene (CA, USA). The pSV-b-galactosidase vector and the luciferase assay kit were purchased from Promega (WI, USA). All other reagents were obtained from Sigma-Aldrich (MO, USA).
Animals & experimental protocol
C57BL/6 mice aged 6 weeks from the National Laboratory Animal Center (Tainan, Taiwan) were employed in this study. All procedures were manipulated in compliance with the Animal Care and Use Guidelines for the China Medical University under a protocol approved by the Institutional Animal Care Use Committee. The experimental protocol was designed and is shown in Figure 1A . Briefly, mice were divided into ten groups (five mice each) and exposed or sham exposed to particles (ZnO-NPs or ZnO-MPs) by micropump nebulizer Zinc oxide nanoparticles impair bacterial clearance by macrophages Research Article (Aerogen, Galway, Ireland) at a high dose (140 µg/ml) or low dose (14 µg/ml) once per day for two consecutive weeks, respectively. The particle exposure doses were dissolved in PBS followed by sonication and immediately applied to mice. Mice were placed in chambers and were exposed to 10 ml of different doses of particles for 30 min. Mice were then infected or uninfected with NTHi (1 × 10 7 CFU) by intranasal injection and sacrificed at 4 h postinfection. The bronchoalveolar lavage fluid (BALF) and isolated lung were collected as described previously [27, 28] . Wright-Giemsa Stain (Sigma-Aldrich) was used to classify the inflammatory cells. The analyses of cytokine secretions and bacterial clearance in BALF were then performed. Lungs were isolated from mice and fixed with 10% neutral phosphate-buffered formalin (Sigma-Aldrich). The tissue sections were prepared and stained with hematoxylin/eosin (H&E). The stained samples were observed and scored using a microscope (Carl Zeiss, Göttingen, Germany). Each specimen was selected using ten vision fields to determine the inflammatory infiltration. The inflammatory responses were evaluated [29] : score 0 -normal lung tissue; score 1 - The mice were exposed to zinc oxide nanoparticles or zinc oxide nanoparticles for 2 weeks under various conditions: untreated (sham-exposed to particles), low particle doses (L; 14 µg/ml) or high particle doses (H; 140 µg/ ml). 4 h after infection with nontypeable Haemophilus influenzae, the mice were sacrificed and levels of nontypeable Haemophilus influenzae surviving in (B) bronchoalveolar lavage fluid and (C) lung tissues were estimated, as described in the 'Materials & methods' section. Summary statistics for the distribution of the data are shown using box plots. supplemented with 10 µg/ml hemin and 10 µg/ml b-nicotinamide adenine (NAD; Sigma-Aldrich) [30] . The NTHi were incubated under 5% CO 2 and 10% O 2 conditions at 37°C for 24 h, and stocked at 4°C before the experiments.
Cytotoxicity assay
The cell viability assay was used to measure the cytotoxicity of ZnO-NPs in RAW264.7 cells as described previously [31] . Briefly, cells (2 × 10 4 ) were seeded in a 96-well culture plate followed by treatment with ZnO-NPs or ZnO-MPs at concentrations of 1, 5, 10 µg/ml (0.26, 1.3, 2.6 µg/cm 2 ) for 24 h. Cells were treated with 200 µg/ ml 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT; Sigma-Aldrich) and incubated for 3 h. Cell viability was measured by the ability of viable cells to reduce MTT (Sigma-Aldrich) to formazan.
Bactericidal assay
NTHi suspensions were adjusted to 0.2 with optical density (OD) at 600 nm and treated with ZnO-NPs or ZnO-MPs at concentrations of 10 0 , 10 1 , 10 2 and 10 3 µg/ ml. The treated bacteria were incubated at 37°C for 24 h and cultured by serial dilution onto chocolate agar. After 24-h incubation, colony-forming units (CFU) were counted to determine bactericidal activity.
Measurement of cytokines
The supernatants from cell cultures were collected, and the levels of keratinocyte-derived chemokines (KCs), IL-6 and TNF-a were determined by using a sandwich ELISA kit (R&D Systems, MN, USA) [32] .
Phagocytosis assay
RAW264.7 cells (5 × 10
5
) were cultured on a 24-well plate for 24 h followed by treatment with ZnO-NPs. The cells were then infected with NTHi for further 3 h at a multiplicity of infection (MOI) of 100. To determine the number of extracellular NTHi, the infected cells were washed with PBS to remove unbound bacteria and then lysed with distilled water for 10 min. Lysates were diluted in PBS, plated onto chocolate agar plates and cultured for 24 h, after which the colony-forming units (CFU) were counted. To determine the number of viable intracellular bacteria, NTHi-infected cells were washed three times with PBS and incubated with gentamicin (100 µg/ml) for 1 h to remove extracellular bacteria [33] . The treated samples were follow ed by the same procedures to determine the number of CFU.
Phagocytosis assay was performed by using fluorescein isothiocyanate (FITC)-conjugated NTHi. NTHi (5 × 10 8 ) were heat killed at 95°C for 5 min. Heat-killed bacteria were incubated with 0.5 mg/ml FITC in 0.1 M carbonate buffer (pH9.0). The FITC-conjugated NTHi were washed three times and suspended in PBS. Macrophages were treated with ZnO-NPs and then incubated for 3 h with FITC-conjugated NTHi. The cells were washed and suspended in PBS containing 0.2% trypan blue to quench fluorescence, which was caused by the binding of bacteria to the surface of cells. Phagocytic activity was determined by flow cytometry (Becton Dickinson, CA, USA) and expressed as the mean fluorescence intensity (MFI) analyzed by Cell Quest software WinMDI (Verity Software House, ME, USA).
Determination of nitric oxide
RAW264.7 cells (5 × 10 5 ) were cultured in 24-well plate for 24 h and treated with ZnO-NPs for 3 h prior to infection with NTHi for 3 h at an MOI of 100. The culture medium was collected and the NO production was determined by using Griess Reagents (Sigma-Aldrich) [34] .
Reverse transcription & quantitative real-time PCR
RAW264.7 cells (5 × 10 5 ) were cultured in a 24-well plate for 24 h and treated with ZnO-NPs for 3 h prior to infection with NTHi for 3 h at an MOI of 100. Total RNA was prepared from ZnO-NP-treated and/or NTHi-infected cells using REzol (PROtech Technologies, Taipei, Taiwan). Total RNA (2 µg) was reverse transcribed into cDNA using the oligo(dT) primer. Quantitative real-time PCR using SYBR Green I Master Mix and a model 7900 Sequence Detector System Table 2 . PCR primers that were used in this study. Zinc oxide nanoparticles impair bacterial clearance by macrophages Research Article (Applied Biosystems, CA, USA) was conducted as described previously [35] . The oligonucleotide primers for PCR amplification of murine iNOS, COX-2 and GAPDH are shown in Table 2 . The PCR program was performed at 50°C for 2 min with 40 cycles of 95°C for 10 s and 60°C for 1 min. The threshold was set above the non-template control background and within the linear phase of target gene amplification in order to calculate the cycle number at which the transcript was detected (denoted as C T ).
Western blot ana lysis RAW264.7 cells (1 × 10 6 ) were cultured in a six-well plate for 24 h and treated with ZnO-NPs for 3 h prior to infection with NTHi for 3 h at an MOI of 100. The prepared cells were washed three times and boiled with SDS-PAGE sample buffer (62.5 mM TrisHCl [pH 6.8], 2% SDS, 10% glycerol, 0.05% brilliant blue R) at 100°C for 10 min. The samples were then resolved by 10% SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Millipore, MA, USA). The membranes were blocked by 5% skim milk in PBST (PBS buffer containing 0.1% Tween 20) at 4°C overnight and then incubated with the first antibodies against COX-2 (dilution 1:2000) and b-actin (dilution 1:10,000) at 4°C overnight. The membranes were then incubated with HRP-conjugated secondary antibodies (Millipore) at a dilution of 1:4000. The proteins of interest were visualized by using the ECL™ Western Blotting Detection Reagents (RE Healthcare, UK) and were detected using ImageQuant LAS-4000 (GE Healthcare, WI, USA).
NF-kB reporter luciferase assay RAW264.7 cells were plated in a 12-well plate and then transfected with a NF-kB-luc reporter plasmid (1 µg) using Lipofectamine 2000 (Invitrogen), as described previously [36] . The transfected cells were lysed, and luciferase assays were performed with the Dual-Luciferase Reporter Assay System and normalized by cotransfection with a b-galactosidase expression vector (Promega, MA, USA).
Immunofluorescence staining of phosphorylated p65 RAW264.7 cells were cultured on coverslips then treated with or without ZnO-NPs for 3 h followed by infection with or without NTHi for an additional 3 h. Cells were fixed, permeabilized and probed with antip65 (H-286; Santa Cruz Biotechnology). Cells were then incubated with a secondary antibody, Alexa Fluor ® 488-conjugated goat anti-mouse IgG (Invitrogen, CA, USA) and propidium iodide (Calbiochem, CA, USA). The nuclear translocation of phosphorylated p65 was observed by a confocal laser scanning microscope (Zeiss LSM 510, Carl Zeiss, Göttingen, Germany). The quantification of fluorescence intensity was performed by ImageJ [34] .
Statistical ana lysis
A Student's t-test and one way ANOVA was employed to calculate the statistical significance of the experimental results between two groups; a p-value less than 0.05 was considered significant.
Results
ZnO-NPs enhance NTHi survival in a murine model of pulmonary infection
We first examined the effects of various concentrations of zinc oxide nanoparticles (ZnO-NPs) and zinc oxide microparticles (ZnO-MPs) on bacterial clearance in a murine model of pulmonary infection ( Figure 1A ). Mice were exposed to different concentrations of ZnO-NPs or ZnO-MPs for 14 days, and were sacrificed 4 h postinfection with NTHi. The number of bacteria remaining in the BALFs and lungs was then assessed. Upon exposure to high concentrations (140 µg/ml) of ZnONPs, NTHi survival increased significantly not only in the BALFs, but also in the lungs ( Figure 1B) . However, bacterial viability was not affected in mice treated with low concentrations (14 µg/ml) of ZnO-NPs or varying concentrations (14 or 140 µg/ml) of ZnO-MPs. These data indicate that inhalation of high concentrations of ZnO-NPs reduce bacterial clearance but does not affect bacterial viability in the lungs.
ZnO-NPs impair macrophage activation
Cell differentiation was then examined in murine BALFs. As shown in Figure 2A , BALF cells significantly increased in number 4 h postinfection with NTHi when compared with noninfected controls. Upon murine exposure to ZnO-NPs followed by infection with NTHi, levels of BALF cells remained high. We then analyzed cell differentiation of infiltrated inflammatory cells in BALFs. Our data showed that regardless of whether they were treated with ZnO-NPs, the numbers of BALF cells, neutrophils, eosinophils and activated macrophages elevated dramatically after infection with NTHi ( Figure 2B-D) . However, the levels of activated macrophages decreased significantly after exposure to high concentrations of ZnO-NPs and infection with NTHi compared with the group not treated with NPs ( Figure 2D ). We also detected the effects of ZnO-MPs on BALF cells. As shown in Supplementary Figure 3 , ZnO-MPs did not clearly affect the BALF cell profiles among the NTHi-treated groups.
Lung tissues isolated from mice were stained with H&E to evaluate levels of infiltrated inflammatory future science group
Research Article Lin, Kou, Liao et al. Figure 3A , inflammatory cell infiltration was absent in lung tissue from mice that were not infected with NTHi or were treated with ZnO-NPs. After infection with NTHi, levels of lung inflammation in mice significantly increased. However, lung inflammatory responses showed no obvious change when mice were exposed to ZnO-NPs prior to challenge with NTHi ( Figure 3B ).
cells. As shown in
ZnO-NPs suppress inflammatory mediator production in BALFs in response to bacterial infection
To investigate the effect of ZnO-NPs on the production of inflammatory mediators/cytokines in BALFs in response to NTHi infection, mice were exposed to ZnO-NPs and then challenged with NHTi for 4 h. After pretreatment with ZnO-NPs alone, the mice showed negligible responses in cytokine secretions, including TNF-a, KC and IL-6 ( Figure 4A-C) . Infection of mice with NTHi resulted in elevated levels of all cytokines tested, similar to those of mice treated with ZnO-NPs and NTHi. Although the level of nitric oxide (NO) was undetectable, mRNA expression of inducible nitric oxide synthase (iNOS) increased markedly in the NTHi-infected group compared with the uninfected group ( Figure 4D ). In comparison with NTHi infection alone, mice exposed to ZnO-NPs and then infected with NTHi Figure 1) . With increased concentrations, we observed that 100 µg/ml of ZnO-NPs had a slight bactericidal effect on NTHi and found that it causes 70% cell death (data not shown). Therefore, ZnO-NP concentrations less than 100 µg/ml (1, 5, 10 µg/ml) were selected to employ in our in vitro bacterial infection model. To further investigate the effects of ZnO-NPs on innate sensing in response to bacterial infection, RAW264.7 cells were exposed to ZnO-NPs before being challenged with NTHi. Our data showed that treating cells with ZnO-NPs (10 µg/ml) enhanced NTHi extracellular survival ( Figure 5A ). However, levels of intracellular NTHi significantly decreased in cells treated with ZnO-NPs ( Figure 5B ). n addition, phagocytosis of FITC-NTHi by macrophages was markedly reduced in the presence of ZnO-NPs ( Figure 5C ). Our data again indicate that phagocytosis of NTHi and bacterial clearance by macrophages was mitigated by ZnO-NPs.
ZnO-NPs inhibit NTHi-induced NO production through the NF-kB signaling pathway
Because NTHi-induced iNOS expression in macrophages was suppressed by ZnO-NPs, we analyzed NO production by measuring nitrite levels. As shown in Figure 6A , the expression of cyclooxygenase 2 (COX-2) in NTHi-infected RAW264.7 cells was inhibited by treatment with ZnO-NPs. NTHi-induced NO production was decreased in a concentration-dependent manner in RAW264.7 cells upon treatment with ZnO-NPs ( Figure 6B ). In parallel, expression of iNOS mRNA was decreased by ZnO-NPs at concentrations of 1-10 µg/ml ( Figure 6C) .
We next investigated the effects of ZnO-NPs on levels of the transcription factor NF-kB, which plays a critical role in the regulation of iNOS expression [37] . The effects of ZnO-NPs on NF-kB expression were then examined using the luciferase assay in RAW264.7 cells transfected with a NF-kB luciferase reporter. As shown in Figure 7A , in the absence of NTHi infection, ZnO-NPs alone did not alter the activation of the NF-kB promoter in macrophages. However, ZnO-NPs significantly inhibited NTHiinduced activation of the NF-kB promoter in a concentration-dependent manner. We then observed p65 localization, which was originally located in the cytosol before treatment of RAW264.7 cells with ZnO-NPs or NTHi (Figure 7B-C) . After infection of cells with NTHi for 3 h, the yellow staining indicates that p65 (green) was translocated into the nucleus (red) of RAW264.7 cells. When cells were treated with ZnO-NPs followed by infection with NTHi, most of the p65 remained in the cytosol. Taken together, these results demonstrate that ZnONPs inhibit NTHi-stimulated NO production and iNOS expression in macrophages via triggering the NF-kB pathway.
Discussion
Absorption of NPs by a host can be mediated through inhalation, ingestion, dermal and parenteral routes [38] . Inhalation is the most common route and may affect the pulmonary immune system, which plays an important role in protection against pathogen infections [39] . Alveolar macrophages primarily responded to NPs, which were inhaled and remained in the lungs [40] . Additionally, macrophages are important to host defense against NTHi [41] . We established a nanoparticle-exposed mouse model and macrophages (RAW264.7) to assess the potential effects of ZnONPs on their ability to influence pulmonary immune activity in response to NTHi infection.
Absorption and tissue biodistribution of particles varies and mainly depends on particle size. In this study, ZnO-NPs enhanced NTHi survival not only in BALFs but also in lung tissue when compared with ZnO-MPs. This result corresponds with our previous findings that ZnO-NPs exhibited better absorption and wider tissue biodistribution than ZnO-MPs in vivo [14] . The organ biodistribution of ZnO-NPs that were administered by oral or intraperitoneal routes has been determined [14] . However, the biodistribution of NPs may differ between systemic administration and inhalation. Therefore, it is essential to evaluate the use of ZnO-NPs in living environments and to assess the tissue biodistribution of ZnO-NPs acquired through inhalation.
ZnO-NPs exhibit bactericidal activity and may kill bacteria by induction of reactive oxygen species (ROS), as has been reported previously [17] . However, the bactericidal effects of ZnONPs on NTHi have not yet Zinc oxide nanoparticles impair bacterial clearance by macrophages Research Article been elucidated. Our results showed that treatment of NTHi with ZnO-NPs (100 µg/ml) for 24 h only slightly affects bacterial viability. Comparing our findings with those of a previous study, which showed that exposure of bacteria to 81.4 µg/ml of ZnO-NPs could completely inhibit the growth of Escherichia coli [17] , indicating that NTHi may have sophisticated mechanisms for enhancing resistance to ZnO-NPs. This finding could be supported by previous evidence that NTHi is able to degrade NO, which may lead to elevated bacterial survival [42] . Production of NO by macrophages is well-known to play pivotal roles in defense against bacterial infection [43, 44] . In this study, exposure of macrophages to ZnO-NPs did not elevate NO production. In contrast, macrophages produced a significant level of NO in response to challenge by NTHi. Although we did not detect iNOS protein expression in the lungs, we suggest that ZnO-NPs might decrease
NTHi-induced iNOS protein expression because they lower iNOS mRNA expression and reduce macrophage activation in the lungs. In addition, in the cell study, we found that ZnO-NPs decrease NTHi-induced NO production in activated macrophages ( Figure 6 ). These results indicate that ZnO-NPs may influence NO-related pathways that subsequently suppress bacterial killing by macrophages. This finding corresponds with previous evidence that NO can mobilize zinc and affect zinc-related proteins [45] , implying that ZnONPs may consume NO, thus protecting pathogens from eradication. Previous studies have indicated that, in addition to physiochemical characteristics, zinc ion (Zn 2+ ) plays a significant role in ZnO-NP-induced cytotoxicity [46, 47] . In contrast, in another study, the authors reported that Zn 2+ is not involved in ZnO-NP-induced cytotoxicity [48] . In the present study, to clarify this important issue, we detected the concentration of Zn 2+ in the culture medium. As shown in Supplementary Table 1 , we detected Zn 2+ in RPMI medium containing 10% FBS in a range of 2000 mg/ ml to 0.003 mg/ml of ZnO-NPs and ZnO-MPs. We found that the maximal Zn 2+ concentration in the medium was approximately 1.3 µg/ml and plateaued at 0.003 mg/ml ZnO-NPs. The inhibitory effects of macrophage function did not show a dose-dependent increase with elevated Zn 2+ concentration. In addition, we found that Zn 2+ concentration in ZnO-MPs showed a similar concentration but did not exhibit inhibitory effects on macrophage activation. Therefore, the conclusion that ZnO-NPs likely inhibit macrophage activation is mainly attributed to ZnO-NPs rather than the concentration of the released zinc ion.
Conclusion
In this study, we established cell and animal models to demonstrate that inhalation of ZnO-NPs impaired NO production and macrophage activation, leading to delayed pathogen clearance. We further revealed that ZnO-NPs inhibited NTHi-stimulated NO production via triggering the NF-kB pathway in macrophages. Our findings indicate that exposure to ZnO-NPs may lead to increased risk for human health, particular in pulmonary infections, by attenuating host immune responses against bacteria.
Future perspective
ZnO-NPs have been used widely in human living environments and the possible toxic effects on human health have raised serious concerns. In this study, inhalation of ZnO-NPs impaired macrophage activation, leading to attenuation of NTHi clearance in a mouse infection model. Our results revealed that ZnO-NPs inhibited NTHi-stimulated NO production via triggering the NF-kB pathway in macrophages. Future work is warranted to investigate the toxicological relevance of ZnO-NPs in the respiratory airway, particularly with respect to host defense against bacterial infection in human. (A) RAW264.7 cells transfected with NF-kB reporter or b-Gal-lacZ (1 µg each) were exposed to ZnO-NPs and infected with or without NTHi at a multiplicity of infection of 100. Luciferase activity was normalized to the expression level of b-Gal-lacZ. (B) Cells were probed with anti-p65 followed by Alexa Fluor ® 488-conjugated goat anti-mouse IgG (green) and propidium iodide to visualize the nucleus (red). Yellow in the merged images indicates colocalization of p65 and the nucleus. (C) The nuclear translocation of phosphorylated p65 was analyzed using confocal microscopy. Scale bars: 10 µm. Statistical significance was evaluated using the Student's t-test. *p < 0.05. NTHi: Nontypeable Haemophilus influenzae; ZnO-NP: ZnO nanoparticle.
•• Breakthrough study providing evidence that oral administration and intraperitoneal injection of ZnO-NPs resulted in their absorption into the circulatory system, followed by biodistribution to the liver, spleen and kidney. 
Executive summary
Background
• Inhalation of nanoparticles (NPs) via the respiratory tract may induce immune-suppressive effects, impairing macrophage functions and attenuating host defenses against bacterial infection.
• How zinc oxide nanoparticles (ZnO-NPs) affect the host pulmonary immune system's response to nontypeable
Haemophilus influenzae (NTHi) infection was investigated.
Materials & methods
• A ZnO-NP-exposed mouse model, which was challenged with NTHi, was established to evaluate pulmonary immune responses and lung bacterial clearance.
• The effect of ZnO-NPs on triggering signalling molecules, which may lead to attenuation of pulmonary immune activation in response to NTHi infection, was investigated.
Results
• Inhalation of high concentrations of ZnO-NPs reduced bacterial clearance in the murine pulmonary system.
• The phagocytosis of NTHi and bacterial clearance by macrophages was mitigated by ZnO-NPs.
• ZnO-NPs inhibit NTHi-stimulated NO production and iNOS expression in macrophages via triggering the NF-kB pathway.
Conclusion
• Our findings indicate that exposure to ZnO-NPs may lead to increased risk for human health, particularly in pulmonary infections, by attenuating the host's immune responses against bacteria.
